Network intelligence

Verge Genomics Inc. has a machine learning platform, data trove and in-house wet lab geared for finding master regulators of complex neurological disease networks that traditional target-hunting approaches miss. The platform has already generated targets and compounds for its lead indication, amyotrophic lateral sclerosis, and netted the newco two pharma partners.

“The traditional pharmaceutical tools are simply not enough to crack the code on neurological diseases,” said CEO Alice Zhang. “Pharma look at single targets in diseases that are caused by hundreds of genes.” ...